Aldeyra Therapeutics, Inc. SEC filings ALDX

Aldeyra Therapeutics, Inc. has 647 filings in SEC EDGAR's recent list, going back to Oct 6, 2005. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Aldeyra Therapeutics, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 29, 2026 Sep 29, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Material agreement
Jul 30, 2026 Jul 28, 2026
8-K Current report
Other events
Jul 15, 2026 Jul 14, 2026
8-K Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
Jun 10, 2026 Jun 9, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Regulation FD disclosure
May 1, 2026 May 1, 2026
ARS Annual report to shareholders Apr 27, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 27, 2026 —
DEF 14A Proxy statement Apr 27, 2026 Jun 10, 2025
8-K Current report
Officer or director change
Apr 20, 2026 Apr 20, 2026
8-K Current report
Other events
Apr 1, 2026 Apr 1, 2026
8-K Current report
Regulation FD disclosure, Other events
Mar 17, 2026 Mar 17, 2026
S-8 Employee stock plan registration Feb 27, 2026 —
10-K Annual report Feb 27, 2026 Dec 31, 2025
8-K Current report
Officer or director change
Dec 31, 2025 Dec 23, 2025
8-K Current report
Regulation FD disclosure, Other events
Dec 16, 2025 Dec 15, 2025
8-K Current report
Regulation FD disclosure, Other events
Nov 13, 2025 Nov 13, 2025
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Other events
Oct 28, 2025 Oct 28, 2025
8-K Current report Aug 19, 2025 Aug 19, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Other events
Jul 17, 2025 Jul 17, 2025
8-K Current report
Regulation FD disclosure, Other events
Jun 26, 2025 Jun 26, 2025
8-K Current report
Other events
Jun 17, 2025 Jun 17, 2025
8-K Current report
Shareholder vote results
Jun 11, 2025 Jun 10, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
8-K Current report
Regulation FD disclosure, Other events
May 6, 2025 May 5, 2025
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Jun 10, 2025
8-K Current report
Officer or director change
Apr 17, 2025 Apr 17, 2025
8-K Current report
Regulation FD disclosure, Other events
Apr 3, 2025 Apr 3, 2025
10-K/A Amended annual report Mar 28, 2025 Dec 31, 2024
S-8 Employee stock plan registration Feb 28, 2025 —
10-K Annual report Feb 28, 2025 Dec 31, 2024
8-K Current report
Material agreement, Other events
Nov 18, 2024 Nov 15, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Other events
Oct 3, 2024 Oct 3, 2024
8-K Current report
Material agreement, New debt
Oct 2, 2024 Sep 30, 2024
8-K Current report
Officer or director change
Sep 3, 2024 Aug 29, 2024
8-K Current report
Regulation FD disclosure, Other events
Aug 8, 2024 Aug 8, 2024
424B5 Prospectus supplement Aug 1, 2024 —
8-K Current report
Material agreement
Aug 1, 2024 Aug 1, 2024
10-Q Quarterly report Aug 1, 2024 Jun 30, 2024
8-K Current report
Other events
Jun 20, 2024 Jun 20, 2024
8-K Current report
Regulation FD disclosure
Jun 13, 2024 Jun 13, 2024
8-K Current report
Shareholder vote results
Jun 7, 2024 Jun 4, 2024
10-Q Quarterly report May 2, 2024 Mar 31, 2024
8-K Current report
Regulation FD disclosure, Other events
Apr 25, 2024 Apr 25, 2024
EFFECT Filing Apr 24, 2024 —
CORRESP Letter to the SEC Apr 22, 2024 —
ARS Annual report to shareholders Apr 22, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 22, 2024 —
DEF 14A Proxy statement Apr 22, 2024 Jun 4, 2024
8-K Current report
Regulation FD disclosure
Mar 28, 2024 Mar 28, 2024
UPLOAD Letter from the SEC Mar 13, 2024 —
S-3 Shelf registration Mar 7, 2024 —
S-8 Employee stock plan registration Mar 7, 2024 —
S-8 POS Filing Mar 7, 2024 —
10-K Annual report Mar 7, 2024 Dec 31, 2023
8-K Current report
Regulation FD disclosure
Feb 13, 2024 Feb 13, 2024
8-K Current report
Other events
Jan 4, 2024 Jan 4, 2024
8-K Current report
Other events
Dec 21, 2023 Dec 21, 2023
8-K Current report
Regulation FD disclosure, Other events
Dec 19, 2023 Dec 19, 2023
8-K Current report
Regulation FD disclosure, Other events
Nov 28, 2023 Nov 27, 2023
S-8 Employee stock plan registration Nov 3, 2023 —
10-Q Quarterly report Nov 3, 2023 Sep 30, 2023
8-K Current report
Material agreement
Nov 1, 2023 Oct 31, 2023
8-K Current report
Other events
Oct 16, 2023 Oct 10, 2023
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Shareholder vote results
Jul 3, 2023 Jun 30, 2023
8-K Current report
Regulation FD disclosure, Other events
Jun 29, 2023 Jun 29, 2023
8-K Current report
Regulation FD disclosure, Other events
Jun 27, 2023 Jun 27, 2023
8-K Current report
Other events
Jun 21, 2023 Jun 21, 2023
8-K Current report
Regulation FD disclosure, Other events
Jun 15, 2023 Jun 15, 2023
ARS Annual report to shareholders May 24, 2023 Dec 31, 2022
DEF 14A Proxy statement May 23, 2023 Jun 30, 2023
10-Q Quarterly report May 4, 2023 Mar 31, 2023
8-K Current report
Results of operations, Other events
May 4, 2023 May 4, 2023
10-K/A Amended annual report Apr 28, 2023 Dec 31, 2022
8-K Current report
Regulation FD disclosure
Mar 10, 2023 Mar 10, 2023
S-8 Employee stock plan registration Mar 9, 2023 —
10-K Annual report Mar 9, 2023 Dec 31, 2022
8-K Current report
Results of operations, Other events
Mar 9, 2023 Mar 9, 2023
8-K Current report
Other events
Mar 2, 2023 Mar 2, 2023
8-K Current report
Other events
Feb 7, 2023 Feb 7, 2023
8-K Current report
Material agreement, New debt, Other events
Dec 27, 2022 Dec 22, 2022
8-K Current report
Other events
Dec 21, 2022 Dec 21, 2022
8-K Current report
Other events
Dec 1, 2022 Dec 1, 2022
8-K Current report
Other events
Nov 29, 2022 Nov 29, 2022
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
8-K Current report
Results of operations, Other events
Nov 10, 2022 Nov 10, 2022
8-K Current report
Regulation FD disclosure, Other events
Oct 6, 2022 Oct 6, 2022
8-K Current report
Other events
Sep 14, 2022 Sep 14, 2022
10-Q Quarterly report Aug 5, 2022 Jun 30, 2022
8-K Current report
Results of operations, Other events
Aug 5, 2022 Aug 5, 2022
8-K Current report
Regulation FD disclosure, Other events
Jul 12, 2022 Jul 12, 2022
8-K Current report
Shareholder vote results, Regulation FD disclosure, Other events
Jun 8, 2022 Jun 7, 2022
8-K Current report
Other events
May 24, 2022 May 24, 2022
8-K Current report
Other events
May 18, 2022 May 18, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
8-K Current report
Results of operations, Other events
May 5, 2022 May 5, 2022
8-K Current report
Officer or director change
Apr 28, 2022 Apr 25, 2022
DEFA14A Additional proxy material Apr 25, 2022 —
DEF 14A Proxy statement Apr 25, 2022 Jun 7, 2022
8-K Current report
Regulation FD disclosure, Other events
Mar 29, 2022 Mar 29, 2022
S-8 Employee stock plan registration Mar 17, 2022 —
10-K Annual report Mar 17, 2022 Dec 31, 2021
8-K Current report
Results of operations, Other events
Mar 17, 2022 Mar 17, 2022
8-K Current report
Regulation FD disclosure, Other events
Dec 21, 2021 Dec 20, 2021
8-K Current report
Other events
Nov 9, 2021 Nov 9, 2021
8-K Current report
Other events
Nov 2, 2021 Nov 2, 2021
10-Q Quarterly report Oct 28, 2021 Sep 30, 2021
8-K Current report
Results of operations, Other events
Oct 28, 2021 Oct 28, 2021
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
8-K Current report
Results of operations, Other events
Aug 5, 2021 Aug 5, 2021
8-K Current report
Shareholder vote results
Jun 9, 2021 Jun 8, 2021
10-Q Quarterly report May 6, 2021 Mar 31, 2021
8-K Current report
Results of operations, Other events
May 6, 2021 May 6, 2021
424B5 Prospectus supplement Apr 29, 2021 —
8-K Current report
Material agreement, Other events
Apr 29, 2021 Apr 27, 2021
424B5 Prospectus supplement Apr 27, 2021 —
8-K Current report
Regulation FD disclosure, Other events
Apr 27, 2021 Apr 27, 2021
8-K Current report
Material agreement, New debt
Apr 21, 2021 Apr 20, 2021
EFFECT Filing Apr 15, 2021 —
DEFA14A Additional proxy material Apr 14, 2021 —
DEF 14A Proxy statement Apr 14, 2021 Jun 8, 2021
CORRESP Letter to the SEC Apr 13, 2021 —
UPLOAD Letter from the SEC Mar 17, 2021 —
S-3 Shelf registration Mar 11, 2021 —
S-8 Employee stock plan registration Mar 11, 2021 —
10-K Annual report Mar 11, 2021 Dec 31, 2020
8-K Current report
Results of operations, Other events
Mar 11, 2021 Mar 11, 2021
8-K Current report
Officer or director change
Jan 25, 2021 Jan 21, 2021
424B5 Prospectus supplement Jan 14, 2021 —
8-K Current report
Material agreement, Other events
Jan 14, 2021 Jan 12, 2021
424B5 Prospectus supplement Jan 13, 2021 —
8-K Current report
Regulation FD disclosure, Other events
Jan 7, 2021 Jan 7, 2021
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations, Other events
Nov 5, 2020 Nov 5, 2020
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
8-K Current report
Results of operations, Other events
Aug 6, 2020 Aug 6, 2020
8-K Current report
Other events
Jul 14, 2020 Jul 14, 2020
8-K Current report
Other events
Jul 7, 2020 Jul 7, 2020
8-K Current report
Shareholder vote results
Jun 12, 2020 Jun 9, 2020
8-K Current report
Other events
Jun 4, 2020 Jun 4, 2020
8-K Current report
Regulation FD disclosure, Other events
May 20, 2020 May 20, 2020
10-Q Quarterly report May 7, 2020 Mar 31, 2020
8-K Current report
Results of operations, Other events
May 7, 2020 May 7, 2020
8-K Current report
Bylaw or fiscal year change
May 1, 2020 Apr 30, 2020
DEFA14A Additional proxy material Apr 27, 2020 —
DEF 14A Proxy statement Apr 27, 2020 Jun 9, 2020
8-K Current report
Other events
Apr 14, 2020 Apr 14, 2020
S-8 Employee stock plan registration Mar 12, 2020 —
10-K Annual report Mar 12, 2020 Dec 31, 2019
8-K Current report
Results of operations, Officer or director change, Other events
Mar 12, 2020 Mar 12, 2020
8-K Current report
Other events
Feb 24, 2020 Feb 24, 2020
8-K Current report
Officer or director change
Jan 14, 2020 Jan 13, 2020
8-K Current report
Regulation FD disclosure, Other events
Dec 3, 2019 Dec 3, 2019
10-Q Quarterly report Nov 7, 2019 Sep 30, 2019
8-K Current report
Results of operations, Other events
Nov 7, 2019 Nov 7, 2019
8-K Current report
Regulation FD disclosure, Other events
Oct 31, 2019 Oct 31, 2019
8-K Current report
Other events
Sep 24, 2019 Sep 24, 2019
8-K Current report
Other events
Sep 3, 2019 Sep 3, 2019
10-Q Quarterly report Aug 9, 2019 Jun 30, 2019
8-K Current report
Results of operations, Other events
Aug 8, 2019 Aug 8, 2019
8-K Current report
Regulation FD disclosure, Other events
Jun 25, 2019 Jun 25, 2019
8-K Current report
Shareholder vote results, Regulation FD disclosure
Jun 6, 2019 Jun 4, 2019
10-Q Quarterly report May 10, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 9, 2019 May 9, 2019
DEFA14A Additional proxy material Apr 22, 2019 —
DEF 14A Proxy statement Apr 22, 2019 Jun 4, 2019
8-K Current report
Material agreement, New debt, Regulation FD disclosure, Other events
Mar 26, 2019 Mar 25, 2019
S-8 Employee stock plan registration Mar 8, 2019 —
10-K Annual report Mar 8, 2019 Dec 31, 2018
8-K Current report
Results of operations
Mar 8, 2019 Mar 8, 2019
8-K Current report
Regulation FD disclosure, Other events
Feb 28, 2019 Feb 28, 2019
D Filing Feb 11, 2019 —
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Other events
Jan 29, 2019 Jan 24, 2019
424B5 Prospectus supplement Dec 28, 2018 —
8-K Current report
Material agreement
Dec 28, 2018 Dec 28, 2018
8-K Current report
Agreement ended
Nov 21, 2018 Nov 20, 2018
10-Q Quarterly report Nov 14, 2018 Sep 30, 2018
8-K Current report
Results of operations
Nov 14, 2018 Nov 14, 2018
CT ORDER Filing Oct 4, 2018 —
8-K Current report
Material agreement, Other events
Sep 28, 2018 Sep 26, 2018
424B5 Prospectus supplement Sep 28, 2018 —
424B5 Prospectus supplement Sep 26, 2018 —
8-K Current report
Regulation FD disclosure, Other events
Sep 26, 2018 Sep 26, 2018
8-K Current report
Other events
Sep 25, 2018 Sep 25, 2018
10-Q Quarterly report Aug 9, 2018 Jun 30, 2018
8-K Current report
Results of operations
Aug 9, 2018 Aug 9, 2018
8-K Current report
Officer or director change
Jul 31, 2018 Jul 27, 2018
EFFECT Filing Jul 27, 2018 —
UPLOAD Letter from the SEC Jul 26, 2018 —
CORRESP Letter to the SEC Jul 25, 2018 —
S-3 Shelf registration Jul 20, 2018 —
8-K Current report
Regulation FD disclosure, Other events
Jun 26, 2018 Jun 26, 2018

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ALDX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Concord, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1341235
Former names
Aldexa Therapeutics, Inc. (until Mar 4, 2014); Neuron Systems Inc (until Aug 1, 2008)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.